Rocket Lab Q3 2026 slides: record $268M revenue, $3.6B backlog

Rocket Lab USA (NASDAQ:RKLB) presented its Q3 2026 investor update on November 9, 2026, showcasing what CEO Peter Beck called the company’s sixth consecutive record revenue quarter. The presentation revealed revenue of $268 million and a record backlog of $3.6 billion, though investor reaction proved mixed as shares initially surged 10.91% to $58.86 before retreating 7.1% in after-hours trading to $54.68.

The volatile stock movement reflected a tension between the company’s strong top-line growth and operational execution on one hand, and higher-than-expected costs and a wider quarterly loss on the other. The company beat revenue expectations by $10.83 million but missed earnings estimates, posting a loss of $0.12 per share versus an expected loss of $0.07.

Rocket Lab’s Q3 2026 results demonstrated substantial growth across its core business segments. The following chart illustrates the company’s remarkable revenue trajectory and improving gross margins over the past six years.

Revenue of $267.8 million represented a 73% year-over-year increase from $155.1 million in Q3 2025 and a 14.4% sequential gain from Q2 2026’s $234.1 million. The Space Systems segment contributed $214.8 million, or approximately 80% of total revenue, driven by SDA Tranche II and III contracts along with component business growth. Launch Services added $53.1 million, bolstered by increased launch cadence.

The company’s financial performance overview highlighted these record achievements:

Gross margins came in above guidance, with GAAP gross margin of 33.6% exceeding the 29-31% forecast and non-GAAP gross margin of 38.4% beating the 35-37% projection. CFO Adam Spice attributed the better-than-expected margin performance to full-quarter contributions from the laser communications acquisition and stronger margins in Solar and Optical Systems.

The company’s detailed quarterly financial breakdown reveals both the strength of revenue growth and the impact of elevated investment spending.

While revenue growth remained robust, the quarter-over-quarter gross margin comparison showed some pressure. GAAP gross margin declined from 36.1% in Q2 to 33.6% in Q3, while non-GAAP gross margin slipped from 41.5% to 38.4%. Management attributed this to a shift toward lower-margin satellite platforms within Space Systems and the removal of one-time benefits that had boosted Q2 results, including over-time revenue recognition and a 100%-margin launch cancellation fee.

Operating expenses increased substantially, driven by continued Neutron development and transaction costs related to the pending Iridium acquisition. The following breakdown shows the sequential increase in both R&D and SG&A spending:

GAAP operating expenses rose to $169.3 million from $142.1 million in Q2, exceeding the company’s guidance range of $143-149 million. Non-GAAP operating expenses increased to $130.2 million from $115.7 million. While GAAP SG&A expenses climbed due to Iridium-related transaction costs, non-GAAP SG&A actually declined sequentially thanks to acquisition synergies.

The company’s key profitability metrics reflected the ongoing investment phase:

Adjusted EBITDA loss widened to $18 million from $8.8 million in Q2, primarily due to elevated R&D spending on the Neutron program. However, GAAP operating cash flow turned positive at $7.2 million, improving $91.2 million sequentially thanks to milestone payments on satellite programs. The company maintained a strong liquidity position with $4.71 billion in cash, cash equivalents, marketable securities, and restricted cash.

One of the presentation’s most striking highlights was the dramatic expansion in both total backlog and new contract signings. The company’s backlog composition showed significant growth in both segments:

Total backlog reached $3.57 billion in Q3 2026, up 51.7% from $2.4 billion in Q2. The composition shifted notably, with Space Systems growing from 40% to 52% of the total, while Launch declined from 60% to 48% despite substantial absolute growth. Government contracts remained the larger customer category at 58%, with commercial work comprising 42%.

Space Systems demonstrated particularly explosive growth in new contract signings:

The segment signed $470 million in new contracts during Q3 2026, a 512% increase from Q3 2025. Year-to-date signings reached $688 million, up 319% from the prior year period. The Space Systems backlog alone stood at $1.7 billion, representing 48% of the company’s total backlog and reflecting 194% year-over-year growth.

Launch contract growth proved equally impressive, with the company announcing over $1 billion in new launch contracts signed during the quarter:

Launch backlog value surged to $1.85 billion at the end of Q3 2026, up from $940.2 million in Q2 and just $509.7 million in Q3 2025. The company now has 117 launches in its backlog, a new record. The dramatic inflection in Q3 reflected major contract wins across Electron, HASTE, and Neutron platforms.

Beyond financial metrics, the presentation emphasized Rocket Lab’s operational achievements in manufacturing and mission delivery. The company highlighted its accelerating production capabilities:

Rocket Lab now builds one rocket every eight days, representing a 37.5% increase in build rate over the past 12 months. This production cadence supports the company’s growing launch backlog and demonstrates scalability in manufacturing operations.

The company’s Electron rocket continues to set industry benchmarks for launch frequency in the small-to-medium launch market:

Based on current schedules, Electron is on track to become the fastest rocket to reach 100 launches, outpacing competitors including Falcon 9, Pegasus, Antares, and others. The chart shows Electron’s trajectory significantly ahead of all comparison vehicles in reaching this milestone.

In the Space Systems segment, Rocket Lab showcased recent mission successes:

The company launched and now operates 12 Rocket Lab-built spacecraft over the past 12 months, including the VICTUS HAZE responsive space mission for the Space Force, twin ESCAPADE spacecraft for Mars science, the MAXWELL communications demonstration for NASA and Viasat, and eight GLOBALSTAR satellite platforms built with MDA Space.

The presentation detailed Rocket Lab’s aggressive acquisition strategy aimed at vertical integration and capability expansion. The company completed multiple strategic acquisitions during the year:

Completed acquisitions include Optical Support Inc, Precision Components Ltd, Mynaric, and Motiv Space Systems, bringing in-house capabilities in laser communications, robotics, precision optics, and manufacturing. The pending Iridium acquisition represents the company’s most ambitious move yet, positioning Rocket Lab to become an end-to-end space company that builds, launches, and operates its own constellation.

Management provided an update on the Iridium transaction’s progress:

The acquisition is fully financed through a completed ATM equity offering, and Iridium shareholders have overwhelmingly approved the transaction. The final step involves obtaining regulatory approvals, with management indicating positive progress with regulators.

A major highlight of the quarter was the pricing power demonstrated in new Neutron contracts:

Rocket Lab sold multiple Neutron missions in Q3 at a new elevated base price of $70 million, up from the previous $55 million price point. This 27% price increase signals strong customer confidence in the medium-lift rocket despite its first flight being delayed to 2027. The company secured commitments from ICEYE, Muon Space, Kepler, Starcloud, and the United States Space Force at the higher price.

The presentation also highlighted $1 billion-plus in launch contracts signed during the quarter across all platforms:

New contracts spanned both confidential defense customers including the United States Space Force and commercial clients such as Synspective, ICEYE, Muon Space, Kepler, and Starcloud. The diversity of customers across government and commercial sectors underscores broad-based demand.

For Q4 2026, Rocket Lab provided guidance reflecting continued revenue growth with improving profitability metrics:

The company expects Q4 revenue between $270 million and $290 million, representing continued year-over-year growth in both Space Systems and Launch segments. GAAP gross margin is projected at 34-36%, with non-GAAP gross margin at 39-41%. Operating expenses are expected to remain elevated at $162-168 million GAAP and $136-142 million non-GAAP as Neutron development continues. Adjusted EBITDA loss is forecast to narrow to $14-20 million, showing sequential improvement from Q3’s $18 million loss.

The company emphasized that approximately 32.9% of its ending Q3 backlog is expected to be recognized within 12 months, with the remaining 67.1% extending beyond that timeframe. Management noted a healthy pipeline of multi-launch deals and large satellite manufacturing contracts, though the size and complexity of these agreements may drive lumpiness in backlog growth quarter to quarter.

While the presentation slides did not detail Neutron’s development timeline, the accompanying earnings call confirmed the rocket’s first flight has been pushed to 2027 due to tank-related issues. However, management emphasized that the first 16 Neutron launches are already booked, with the next available launch slots pushed into the 2030s, demonstrating sustained customer demand despite the delay.

The mixed market reaction to Rocket Lab’s Q3 results highlighted the tension between the company’s strong growth trajectory and its ongoing investment phase. Shares closed regular trading up 10.91% at $58.86, reflecting enthusiasm for the record revenue, backlog growth, and contract signings. However, after-hours trading saw a 7.1% decline to $54.68 as investors digested the wider-than-expected loss and elevated operating expenses.

The company’s current valuat